Trends in the incidence and death from cancer from 1989-2003 in the Netherlands;Trends in incidentie van en sterfte aan kanker in de periode 1989-2003 in Nederland

Nederlands Tijdschrift voor Geneeskunde

Volumn 150, Issue 45, 2006, Pages 2490-2496

  Siesling, S ^a   Visser, O ^b   Van Dijck, J A A M ^c,d   Coebergh, J W W ^e,f  

^a Integraal Kankercentrum Stedendriehoek Twente   (Netherlands)

^b Integraal Kankercentrum Amsterdam   (Netherlands)

^c Integraal Kankercentrum Oost   (Netherlands)

^d RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^e The Netherlands   (Netherlands)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL CONSUMPTION; ARTICLE; BREAST CANCER; CANCER; CANCER MORTALITY; CANCER REGISTRY; CANCER SUSCEPTIBILITY; COLON CANCER; GALLBLADDER CANCER; HUMAN; INCIDENCE; LUNG CANCER; MELANOMA; NETHERLANDS; PROGNOSIS; PROSTATE CANCER; SEX DIFFERENCE; SKIN CANCER; SMOKING; STOMACH CANCER;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; MORTALITY; NEOPLASMS; NETHERLANDS; REGISTRIES; RETROSPECTIVE STUDIES; RISK FACTORS; SEX DISTRIBUTION;

EID: 33751197690     PISSN: 00282162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Visser O, Coebergh JWW, Dijck JAAM van, Siesling S. Incidence of cancer in the Netherlands 1998. Utrecht: Vereniging van Integrale Kankercentra; 2002.
2. Schouten LJ, Jager JJ, Brandt PA van den. Quality of cancer registry data: a comparison of data provided by clinicians with those of registration personnel. Br J Cancer. 1993;68:974-7.
3. International classification of diseases for oncology. 3rd ed. Genève: WHO; 1976.
4. Hermanek P, Sobin LH. TNM classification of malignant tumours. UICC International Union Against Cancer. Berlijn: Springer; 1987.
5. Janssen-Heijnen ML, Nab HW, Reek J van, Heijden LH van der, Schipper R, Coebergh JWW. Striking changes in smoking behaviour and lung cancer incidence by histological type in south-east Netherlands, 1960-1991. Eur J Cancer. 1995;31A:949-52.
6. Janssen-Heijnen ML, Coebergh JWW, Klinkhamer PJ, Schipper RM, Splinter TA, Mooi WJ. Is there a common etiology for the rising incidence of and decreasing survival with adenocarcinoma of the lung? Epidemiology. 2001;12:256-8.
7. Brennan P, Bray I. Recent trends and future directions for lung cancer mortality in Europe. Br J Cancer. 2002;87:43-8.
8. Crocetti E, Paci E. Trends in lung adenocarcinoma incidence and survival. Lung Cancer. 2002;35:215-6.
9. Janssen-Heijnen ML, Coebergh JWW. Trends in incidence and prognosis of the histological subtypes of lung cancer in North America, Australia, New Zealand and Europe. Lung Cancer. 2001;31:123-37.
10. Levi F, Randimbison L, la Vecchia C, Erler G, Te VC. Multiple primary cancers to indicate associations between smoking and cancer incidence: Vaud and Neuchatel, Switzerland, 1974-1994. Int J Cancer. 1998; 76:913-4.
11. Brekelmans CT. Risk factors and risk reduction of breast and ovarian cancer. Curr Opin Obstet Gynecol. 2003;15:63-8.
12. Signaleringscommissie Kanker van KWF Kankerbestrijding. De rol van lichaamsbeweging bij preventie van kanker. Den Haag: KWF Kankerbestrijding; 2005.
13. Laheij RJH, Straatman H, Verbeek ALM. Mortality trend from cancer of the gastric cardia in the Netherlands, 1969-1994. Int J Epidemiol. 1999;28:391-5.
14. Bosetti C, Negri E, Trichopoulos D, Franceschi S, Beral V, Tzonou A, et al. Long-term effects of oral contraceptives on ovarian cancer risk. Int J Cancer. 2002;102:262-5.
15. Kiemeney LA, Verbeek ALM, Nelemans PJ, Witjes JA, Straatman H. Bladder cancer mortality in the Netherlands, 1955-1988. Br J Urol. 1992;70:46-52.
16. Fracheboud J, Otto SJ, Groenewoud JH, Ineveld BM van, Broeders MJM, Verbeek ALM, et al. Landelijke evaluatie van bevolkingsonderzoek naar borstkanker in Nederland. Rotterdam: National Evaluation Team for Breast Cancer; 2001.
17. Dijck JAAM van, Hendriks JHCL, Holland R, Schouten LJ, Verbeek ALM. Veranderde stadiumverdeling van borstkanker sinds de invoering van de landelijke screening; onderzoek over de periode 1989-1995. Ned Tijdschr Geneeskd. 2000;144:1119-24.
18. Levi F, Lucchini F, Negri E, la Vecchia C. Cancer mortality in the European Union, 1988-1997: the fall may approach 80,000 deaths a year. Int J Cancer. 2002;98:636-7.
19. Dos Santos Silva I, Swerdlow AJ. Recent trends in incidence of and mortality from breast, ovarian and endometrial cancers in England and Wales and their relation to changing fertility and oral contraceptive use. Br J Cancer. 1995;72:485-92.
20. Graaf Y van der, Zielhuis GA, Vooijs GP. Cervical cancer mortality in the Netherlands. Int J Epidemiol. 1988;17:270-6.
21. Ballegooijen M van, Hermens R. Cervical cancer screening in the Netherlands. Eur J Cancer. 2000;36:2244-6.
22. Coebergh JWW, Janssen ML, Louwman M, Voogd AC. Cancer, incidence, care and survival in the South of the Netherlands, 1955-1999; a report of the Eindhoven Cancer Registry with cross-border implications. Eindhoven: Comprehensive Cancer Centre South (IKZ); 2001.
23. Hemminki K, Li X, Mutanen P. Age-incidence relationships and time trends in cervical cancer in Sweden. Eur J Epidemiol. 2001;17: 323-8.
24. Levi F, Lucchini F, Negri E, Franceschi S, la Vecchia C. Cervical cancer mortality in young women in Europe: patterns and trends. Eur J Cancer. 2000;36:2266-71.
25. Giard RWM, Coebergh JWW, Casparie-van Velzen IJAMG. Sterke stijging van de detectiefrequentie van prostaatkanker in Nederland gedurende de periode 1990-1996. Ned Tijdschr Geneeskd. 1998;142: 1958-62.
26. Blanks RG, Moss SM, McGahan CE, Quinn MJ, Babb PJ. Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality. BMJ. 2000;321:665-9.
27. Baade PD, Coory MD, Aitken JF. International trends in prostate-cancer mortality: the decrease is continuing and spreading. Cancer Causes Control. 2004;15:237-41.
28. Hayne D, Brown RS, McCormack M, Quinn MJ, Payne HA, Babb P. Current trends in colorectal cancer: site, incidence, mortality and survival in England and Wales. Clin Oncol (R Coll Radiol). 2001;13: 448-52.
29. Martijn H, Voogd AC, Poll-Franse LV van de, Repelaer van Driel OJ, Rutten HJ, Coebergh JWW, et al. Improved survival of patients with rectal cancer since 1980: a population-based study. Colorectal Cancer Study Group of the Comprehensive Cancer Centre South (IKZ). Eur J Cancer. 2003;39:2073-9.
30. Peeters KC, Kapiteijn E, Velde CJ van de. Managing rectal cancer: the Dutch experience. Dutch ColoRectal Cancer Group. Colorectal Dis. 2003;5:423-6.
31. Nagtegaal ID, Velde CJ van de, Marijnen CA, Krieken JH van, Quirke P. Low rectal cancer: a call for a change of approach in abdomino-perineal resection. Dutch Colorectal Cancer Group. The Pathological Review Committee. J Clin Oncol. 2005;23:9257-64.
32. Spronsen DJ van, Dijkema IM, Vrints LW, Hofstra G, Crommelin MA, Erdkamp FLG, et al. Improved survival of Hodgkin's patients in south-east Netherlands since 1972. Eur J Cancer. 1997;33:436-41.
33. Thomas DA, Faderl S, O'Brien S, Bueso-Ramos C, Cortes J, Garcia-Manero G, et al. Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia. Cancer. 2006;106:1569-80.
34. Manfredi S, Benhamiche AM, Isambert N, Prost P, Jouve JL, Faivre J. Trends in incidence and management of gallbladder carcinoma: a population-based study in France. Cancer. 2000;89:757-62.